DCT and neoplasm: We demonstrate that after immunization with the MCMV-TRP2 vector, the protection against tumor outgrowth mediated by the elicited polyclonal TRP2 antibodies is completely abrogated in FcγRI-deficient mice and partially diminished in FcγRIV−/− mice.